More tools:Markets·Screener·Research·Chat

DNA X, Inc. Common Stock (SONM) Financial Statements

DNA X, Inc. Common Stock
SIC 3661 · TELEPHONE & TELEGRAPH APPARATUS
FIGI BBG001SMF920
XNAS · usd
3.13▼ 0.11 (-3.40%)
As of 2026-09-08
Valuation
Market Cap
Enterprise Value
Trailing P/E—
Price / Sales—
EV / Revenue—
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin—
Net Debt
Trading Information
Previous Close3.24
Day's Range3.03 – 3.22
52-Week Range0.55 – 12.30
Volume10.4K
Avg Volume11.7K
Share Statistics
Shares Outstanding
Employees4
ExchangeXNAS
Listed2019-05-10
Share count as of August 18, 2026
Loading Income Statement…
Key questions about DNA X, Inc. Common Stock (SONM)
What is DNA X, Inc. Common Stock's Market Cap?
DNA X, Inc. Common Stock's Market Cap is $4.7M, based on as-reported figures from SEC (XBRL) filings.
What is DNA X, Inc. Common Stock's Enterprise Value?
DNA X, Inc. Common Stock's Enterprise Value is $8.8M, based on as-reported figures from SEC (XBRL) filings.
What is DNA X, Inc. Common Stock's EV / EBITDA?
DNA X, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is DNA X, Inc. Common Stock's Revenue (TTM)?
DNA X, Inc. Common Stock's Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.
What is DNA X, Inc. Common Stock's Net Income (TTM)?
DNA X, Inc. Common Stock's Net Income (TTM) is -$8.5M, based on as-reported figures from SEC (XBRL) filings.
What is DNA X, Inc. Common Stock's EBITDA?
DNA X, Inc. Common Stock's EBITDA is -$5.4M, based on as-reported figures from SEC (XBRL) filings.
What is DNA X, Inc. Common Stock's Diluted EPS (TTM)?
DNA X, Inc. Common Stock's Diluted EPS (TTM) is -5.74, based on as-reported figures from SEC (XBRL) filings.
What is DNA X, Inc. Common Stock's Net Debt?
DNA X, Inc. Common Stock's Net Debt is $4.2M, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenue———
YoY growth———+7.9%
Operating expenses
Selling, General and Administrative Expense
Total operating expenses
% of revenue———35.7%
Net loss from operations
% of revenue———-24.5%
Net income (loss)
% of revenue———-29.3%
Earnings Per Share (Basic)
Earnings Per Share (Diluted)—